Global  

F.D.A. Grants Emergency Authorization of Antibody Treatment Given to Trump

NYTimes.com Sunday, 22 November 2020 ()
The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease.
0
shares
ShareTweetSavePostSend
 
Video Credit: Wochit News - Published
News video: The WHO No Longer Recommends Remdesivir For COVID-19 Patients

The WHO No Longer Recommends Remdesivir For COVID-19 Patients 00:39

The FDA approved remdesivir as a treatment for severe COVID-19 cases last month. This is after granting emergency authorization in May, reports Business Insider. But on Thursday, the WHO announced it will not recommend the drug's use for COVID-19 patients. "There is currently no evidence that it...

You Might Like


Related videos from verified sources

Eli Lilly Receives Emergency Use Authorization For Antibody Drug [Video]

Eli Lilly Receives Emergency Use Authorization For Antibody Drug

Drug company Eli Lilly has received emergency use authorization for its antibody drug, which is similar to the antibody drug President Trump received, but there have been numerous antibodies in various..

Credit: CBS 2 New York     Duration: 01:58Published
COVID-19 Antibody Gets FDA Emergency Authorization [Video]

COVID-19 Antibody Gets FDA Emergency Authorization

Studies found the treatment lowered the risk of hospitalization and eased some symptoms, KDKA's Chris Hoffman reports.

Credit: KDKA CBS 2 Pittsburgh     Duration: 01:26Published
Regeneron says its COVID-19 drug cut patient visits [Video]

Regeneron says its COVID-19 drug cut patient visits

Regeneron said on Wednesday its coronavirus antibody cocktail - used to treat U.S. President Donald Trump - significantly reduced medical visits in a trial of nearly 800 patients. Gloria Tso reports.

Credit: Reuters - Politics     Duration: 01:56Published

Related news from verified sources

FDA Grants Emergency Authorization For A Second COVID-19 Antibody Treatment

The experimental cocktail from the bio-tech company Regeneron is the same drug President Trump got when he was battling the coronvirus earlier this year. It is...
NPR

U.S. FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump

The company said it expects to have does of REGEN-COV2 treatment ready for about 80,000 patients by the end of this month, about 200,000 patients by the first...
Haaretz

FDA Grants Emergency Use Approval To Regeneron's COVID-19 Antibody Therapy

Regeneron's investigational COVID-19 antibody therapy REGN-COV2, which was administrated to U.S. President Donald Trump, has received emergency use authorization...
RTTNews